tiprankstipranks
Seres Therapeutics (DE:1S90)
FRANKFURT:1S90
Germany Market
1S90
Seres Therapeutics
RESEARCH TOOLSreports

Seres Therapeutics (1S90) Income Statement

1 Followers

Seres Therapeutics Income Statement

Last quarter (Q4 2025), Seres Therapeutics's total revenue was $438.00K, an increase of Infinity% from the same quarter last year. In Q4, Seres Therapeutics's net income was $-15.34M. See Seres Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 789.00K$ 0.00$ 0.00$ 0.00$ 144.93M
Gross Profit
$ -3.34M$ -3.53M$ 0.00$ 0.00$ 144.93M
Operating Expenses
$ 90.63M$ 117.78M$ 195.10M$ 179.91M$ 209.42M
Depreciation and Amortization
$ 4.13M$ 5.47M$ 6.24M$ 6.63M$ 5.95M
EBITDA
$ -89.84M$ -120.30M$ -181.42M$ -170.93M$ -56.72M
Operating Income
$ -93.97M$ -121.31M$ -195.10M$ -179.91M$ -64.49M
Other Income/Expenses
$ 99.67M$ -4.46M$ 4.97M$ -3.67M$ -1.08M
Pretax Income
$ 5.70M$ -125.77M$ -190.13M$ -183.58M$ -65.58M
Net Income
$ 5.70M$ 136.00K$ -113.72M$ -250.16M$ -65.58M
Per Share Metrics
Basic EPS
$ 0.64$ -18.86$ -17.77$ -46.29$ -14.30
Diluted EPS
$ 0.64$ -18.86$ -17.77$ -46.29$ -14.30
Weighted Average Shares Outstanding
 8.86M 7.77M 6.40M 5.40M 4.59M
Weighted Average Shares Outstanding (Diluted)
 8.87M 7.77M 6.40M 5.40M 4.59M
Currency in USD

Seres Therapeutics Earnings and Revenue History